Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial

PLoS One. 2023 Jul 11;18(7):e0288440. doi: 10.1371/journal.pone.0288440. eCollection 2023.

Abstract

Public interest in low-carbohydrate (LC) diets for type 1 diabetes (T1D) management has increased. This study compared the effects of a healthcare professional delivered LC diet compared to habitual diets higher in carbohydrates on clinical outcomes in adults with T1D. Twenty adults (18-70 yrs) with T1D (≥6 months duration) with suboptimal glycaemic control (HbA1c>7.0% or >53 mmol/mol) participated in a 16-week single arm within-participant, controlled intervention study involving a 4-week control period following their habitual diets (>150 g/day of carbohydrates) and a 12-week intervention period following a LC diet (25-75 g/day of carbohydrates) delivered remotely by a registered dietitian. Glycated haemoglobin (HbA1c -primary outcome), time in range (blood glucose: 3.5-10.0 mmol/L), frequency of hypoglycaemia (<3.5 mmol/L), total daily insulin, and quality of life were assessed before and after the control and intervention periods. Sixteen participants completed the study. During the intervention period, there were reductions in total dietary carbohydrate intake (214 to 63 g/day; P<0.001), HbA1c (7.7 to 7.1% or 61 to 54 mmol/mol; P = 0.003) and total daily insulin use (65 to 49 U/day; P<0.001), increased time spent in range (59 to 74%; P<0.001), and improved quality of life (P = 0.015), with no significant changes observed during the control period. Frequency of hypoglycaemia episodes did not differ across timepoints, and no episodes of ketoacidosis or other adverse events were reported during the intervention period. These preliminary findings suggest that a professionally supported LC diet may lead to improvements in markers of blood glucose control and quality of life with reduced exogenous insulin requirements and no evidence of increased hypoglycaemia or ketoacidosis risk in adults with T1D. Given the potential benefits of this intervention, larger, longer-term randomised controlled trials are warranted to confirm these findings. Trial Registration: https://www.anzctr.org.au/ACTRN12621000764831.aspx.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 1* / therapy
  • Diet, Carbohydrate-Restricted
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemia*
  • Insulin, Regular, Human
  • Ketosis*
  • Quality of Life

Substances

  • Glycated Hemoglobin
  • Insulin, Regular, Human

Associated data

  • ANZCTR/ACTRN12621000764831

Grants and funding

This study has been partially funded by The Commonwealth Scientific and Industrial Research Organisation (CSIRO) who kindly donated $6000 AUD to this research project. We also raised philanthropic funds (University of Sydney crowd-sourcing platform) to the amount of ~$7000 AUD to cover remaining costs. The Type 1 Diabetes Family Centre agreed to reimburse the study diabetes educator for their time (up to 30 hours) so they could perform their necessary role in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.